Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1989/003025external-prioritypatent/WO1990000902A1/en
Application filed by Chiron CorpfiledCriticalChiron Corp
Publication of FI954230A0publicationCriticalpatent/FI954230A0/en
Publication of FI954230ApublicationCriticalpatent/FI954230A/en
Application grantedgrantedCritical
Publication of FI102115BpublicationCriticalpatent/FI102115B/en
Publication of FI102115B1publicationCriticalpatent/FI102115B1/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Peptides Or Proteins
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
The invention concerns a diagnostic test pack and a monoclonal antibody composition useable therein, said monoclonal antibody reacting with human TNF (tumor necrosis factor, cachectin).
FI954230A1988-07-181995-09-08Monoclonal antibody composition for use as a diagnostic reagent
FI102115B1
(en)
Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
MONOCLONAL ANTIKROPP REAKTIV FOER EN VISST VIDSTRAECKT I OLIKA MAENSKOLEUKEMI- OCH LYMFOMACELLER FOEREKOMMANDE ANTIGEN OCH METODER FOER DESS ANVAENDNING I DIAGNOS OCH VAORD.